Company: EDSA
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001171843-25-000866
Chunk: 81

Company: Edesa Biotech, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part II, Item 4
Chunk 81
---
 general incorporation language in such filing.

23

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Date: February 14, 2025
			EDESA BIOTECH, INC.

			/s/ Pardeep Nijhawan

			Pardeep Nijhawan, MD, Director, Chief Executive Officer and Corporate Secretary

			(Principal Executive Officer)

			Date: February 14, 2025

			/s/ Stephen Lemieux

			Stephen Lemieux, Chief Financial Officer

			(Principal Financial Officer and Duly Authorized Officer)

24